LSC Webinars CELL All
-
Viral Safety Testing In Biologics: Detecting What Current Methods Miss
6/10/2026
Biologics face unpredictable risks as complexity grows; evolving testing strategies to broaden detection, address gaps, and strengthen safety confidence without disrupting development or compliance.
-
Efficient mAb Development With A Flexible Purification Toolkit
6/4/2026
Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.
-
From Gene Editing To NGS-Based T Cell Characterization
6/4/2026
Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.
-
How Solid-State Science Solves Your Toughest API Challenges
6/3/2026
Difficult small molecules demand more than standard purification strategies. See how combining solid-state expertise with advanced chromatographic modeling improves filtration, purity, and scalability.
-
2026 Critical Manufacturing Trends Reshaping Pharma & Medical Device
6/3/2026
Discover how modern life sciences manufacturers integrate digital threads and validated AI frameworks to eliminate operational silos, build supply chain resilience, and upskill the modern workforce.
-
Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing
6/2/2026
See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.
-
Challenges And Opportunities With Novel AAV Capsids
6/2/2026
Explore challenges and solutions in developing novel AAV capsids, focusing on manufacturing complexity, analytical testing, and regulatory considerations for advancing gene therapy effectiveness.
-
From Complexity To Confidence: Supporting Tech Transfer With A Prefillable Syringe System
6/2/2026
Discover how aligning packaging strategy with technology transfer requirements can accelerate timelines, control costs, and support successful injectable drug product manufacturing.
-
CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic
5/29/2026
As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.
-
Quality By Design: The Future Of Automated Pharmaceutical Labeling
5/28/2026
Learn how applying Quality by Design principles to automated labeling platforms utilizes robotics to eliminate manual errors and seamlessly adapt to future pharmaceutical packaging formats.